Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Philip

Showing results (411-420 of 520) with videos related to

Pageof 52
Sort By:
Oncotarget|November 22, 2017
Comparative molecular analyses of left-sided colon, right-sided colon, and rectal cancersMohamed E Salem, Benjamin A Weinberg, Joanne Xiu, et al.
International Journal of Molecular Sciences|October 2, 2019
Targeting Nuclear Exporter Protein XPO1/CRM1 in Gastric CancerRachel Sexton, Zaid Mahdi, Rahman Chaudhury, et al.
Biomaterials Research|April 1, 2021
In vivo tumour imaging employing regional delivery of novel gallium radiolabelled polymer compositesRoss W Stephens, Gregory D Tredwell, Jessica L Bell, et al.
Scientific Reports|November 6, 2015
Targeting the Nuclear Export Protein XPO1/CRM1 Reverses Epithelial to Mesenchymal TransitionAsfar S Azmi, Irfana Muqbil, Jack Wu, et al.
Frontiers in Oncology|November 11, 2021
High-Risk Features Are Prognostic in dMMR/MSI-H Stage II Colon CancerAmr Mohamed, Renjian Jiang, Philip A Philip, et al.
Annals of Surgical Oncology|August 6, 2003
Histopathologic evidence of tumor regression in the axillary lymph nodes of patients treated with preoperative chemotherapy correlates with breast cancer outcomeLisa A Newman, Nat L Pernick, Volkan Adsay, et al.
Advances in Radiation Oncology|December 8, 2022
Targeting Cellular Metabolism With CPI-613 Sensitizes Pancreatic Cancer Cells to Radiation TherapyHusain Yar Khan, Mandana Kamgar, Amro Aboukameel, et al.
Cancer|February 11, 2025
Chemotherapy dose density is prognostic for overall survival in patients with resectable pancreas cancer: A landmark analysis of SWOG 1505Sameer H Patel, Sarah Colby, Davendra Sohal, et al.
Journal of Ovarian Research|November 15, 2024
Targeting mitochondrial metabolism with CPI-613 in chemoresistant ovarian tumorsMary P Udumula, Faraz Rashid, Harshit Singh, et al.
Oncotarget|May 31, 2011
Network modeling of MDM2 inhibitor-oxaliplatin combination reveals biological synergy in wt-p53 solid tumorsAsfar S Azmi, Sanjeev Banerjee, Shadan Ali, et al.
Pageof 52

Showing results (411-420 of 520) with videos related to

Sort By:
Pageof 52
Oncotarget|November 22, 2017
Comparative molecular analyses of left-sided colon, right-sided colon, and rectal cancersMohamed E Salem, Benjamin A Weinberg, Joanne Xiu, et al.
International Journal of Molecular Sciences|October 2, 2019
Targeting Nuclear Exporter Protein XPO1/CRM1 in Gastric CancerRachel Sexton, Zaid Mahdi, Rahman Chaudhury, et al.
Biomaterials Research|April 1, 2021
In vivo tumour imaging employing regional delivery of novel gallium radiolabelled polymer compositesRoss W Stephens, Gregory D Tredwell, Jessica L Bell, et al.
Scientific Reports|November 6, 2015
Targeting the Nuclear Export Protein XPO1/CRM1 Reverses Epithelial to Mesenchymal TransitionAsfar S Azmi, Irfana Muqbil, Jack Wu, et al.
Frontiers in Oncology|November 11, 2021
High-Risk Features Are Prognostic in dMMR/MSI-H Stage II Colon CancerAmr Mohamed, Renjian Jiang, Philip A Philip, et al.
Annals of Surgical Oncology|August 6, 2003
Histopathologic evidence of tumor regression in the axillary lymph nodes of patients treated with preoperative chemotherapy correlates with breast cancer outcomeLisa A Newman, Nat L Pernick, Volkan Adsay, et al.
Advances in Radiation Oncology|December 8, 2022
Targeting Cellular Metabolism With CPI-613 Sensitizes Pancreatic Cancer Cells to Radiation TherapyHusain Yar Khan, Mandana Kamgar, Amro Aboukameel, et al.
Cancer|February 11, 2025
Chemotherapy dose density is prognostic for overall survival in patients with resectable pancreas cancer: A landmark analysis of SWOG 1505Sameer H Patel, Sarah Colby, Davendra Sohal, et al.
Journal of Ovarian Research|November 15, 2024
Targeting mitochondrial metabolism with CPI-613 in chemoresistant ovarian tumorsMary P Udumula, Faraz Rashid, Harshit Singh, et al.
Oncotarget|May 31, 2011
Network modeling of MDM2 inhibitor-oxaliplatin combination reveals biological synergy in wt-p53 solid tumorsAsfar S Azmi, Sanjeev Banerjee, Shadan Ali, et al.
Pageof 52